Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:35 pm Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 1,001,350 1.990% | -1,626,301 (-61.89%) | Filing History |
| 2025-08-14 1:07 pm Purchase | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | T. Rowe Price Associates, Inc. | 3,461,510 6.900% | 1,060,722 (+44.18%) | Filing History |
| 2025-08-14 11:16 am Purchase | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 5,308,009 10.500% | 155,340 (+3.01%) | Filing History |
| 2025-08-14 07:13 am Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Avoro Capital Advisors LLC | 2,050,000 4.100% | -131,000 (-6.01%) | Filing History |
| 2025-08-12 8:52 pm Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings, L.P. | 3,958,294 7.400% | -500,000 (-11.22%) | Filing History |
| 2025-08-12 09:05 am Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 3,575,964 7.100% | -816,732 (-18.59%) | Filing History |
| 2025-08-07 10:17 am Purchase | 2025-07-31 | 13G | Soleno Therapeutics, Inc. SLNO | FMR LLC | 7,833,778 15.000% | 4,495,920 (+134.69%) | Filing History |
| 2025-08-06 12:14 pm Purchase | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | FMR LLC | 3,337,858 6.600% | 3,337,858 (New Position) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | BlackRock Inc. BLK | 2,766,225 5.500% | 756,435 (+37.64%) | Filing History |
| 2025-05-14 12:02 pm Sale | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 5,152,669 11.200% | -35,596 (-0.69%) | Filing History |
| 2025-05-14 10:45 am Purchase | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | T. Rowe Price Associates, Inc. | 2,400,788 5.200% | 2,400,788 (New Position) | Filing History |
| 2025-05-12 09:06 am Purchase | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 4,392,696 9.580% | 1,070,550 (+32.22%) | Filing History |
| 2025-04-30 5:15 pm Sale | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 2,627,651 5.600% | -1,721,784 (-39.59%) | Filing History |
| 2025-03-31 8:00 pm Sale | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings, L.P. | 4,458,294 9.700% | -1,833,557 (-29.14%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 4,349,435 9.990% | 398,148 (+10.08%) | Filing History |
| 2025-02-14 11:56 am Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 5,188,265 12.000% | 1,107,166 (+27.13%) | Filing History |
| 2025-02-12 09:34 am Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,775,976 6.440% | 949,162 (+51.96%) | Filing History |
| 2025-02-05 5:28 pm Sale | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | BlackRock Inc. BLK | 2,009,790 4.700% | -2,027 (-0.10%) | Filing History |
| 2024-11-19 9:44 pm Sale | 2024-11-14 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 1,770,792 4.100% | -1,684,184 (-48.75%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 3,951,287 9.990% | 3,951,287 (New Position) | Filing History |